About this item:

112 Views | 76 Downloads

Author Notes:

Correspondence: Matthew L. Paden, Department of Pediatrics, Emory University, 1405 Clifton Road, Atlanta, GA 30322. E-mail: matthew.paden@choa.org

Disclosure: Dr. Brodie receives research support from ALung Technologies, he was previously on their medical advisory board. He has been on the medical advisory boards for Baxter, BREETHE, Xenios and Hemovent. The other authors have no conflicts of interest to report.

Subjects:

Research Funding:

None declared

Keywords:

  • Science & Technology
  • Technology
  • Life Sciences & Biomedicine
  • Engineering, Biomedical
  • Transplantation
  • Engineering
  • extracorporeal membrane oxygenation
  • acute respiratory distress syndrome
  • COVID-19
  • pandemic

Initial ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure

Show all authors Show less authors

Tools:

Journal Title:

ASAIO JOURNAL

Volume:

Volume 66, Number 5

Publisher:

, Pages 472-474

Type of Work:

Article | Final Publisher PDF

Abstract:

Disclaimer: ECMO has, and will certainly continue, to play a role in the management of COVID-19 patients. It should be emphasized that this initial guidance is based on the current best evidence for ECMO use during this pandemic. Guidance documents addressing additional portions of ECMO care are currently being assembled for rapid publication and distribution to ECMO centers worldwide.

Copyright information:

© 2020 by the ASAIO.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote